Prednisone Dosing and Tapering for Acute Asthma Exacerbations
For acute asthma exacerbations, adults should receive 40-80 mg/day of prednisone in 1-2 divided doses until peak expiratory flow reaches 70% of predicted (typically 5-10 days), and children should receive 1-2 mg/kg/day (maximum 60 mg/day) in 2 divided doses for 3-10 days; no taper is necessary for courses ≤10 days, especially if patients are concurrently taking inhaled corticosteroids. 1, 2
Adult Dosing
Initial Treatment
- Dose: 40-80 mg/day of oral prednisone in 1 or 2 divided doses 1, 2
- Duration: Continue until peak expiratory flow (PEF) reaches 70% of predicted or personal best 1, 2
- Typical course: 5-10 days for outpatient "burst" therapy 1, 2
Key Prescribing Points
- No advantage to higher doses: There is no proven benefit for doses exceeding 80 mg/day in severe exacerbations 1, 2
- Oral equals IV: Oral administration is as effective as intravenous therapy provided gastrointestinal absorption is intact 1, 2, 3
- Timing: Administer in the morning (prior to 9 AM) to minimize adrenal suppression, as this aligns with peak cortisol activity 4
Pediatric Dosing (Prednisolone Preferred)
Initial Treatment
- Dose: 1-2 mg/kg/day in 2 divided doses 1, 2
- Maximum: 60 mg/day 1, 2
- Duration: 3-10 days 1, 2
- Continue until: Child achieves PEF of 80% of personal best or symptoms resolve 5
Evidence on Pediatric Dosing
Recent evidence suggests 1 mg/kg/day is non-inferior to 2 mg/kg/day for moderate exacerbations in preschool children (ages 1-5 years), with significantly less vomiting at the lower dose 6. However, the NHLBI guidelines support the 1-2 mg/kg/day range for uncontrolled asthma 5, so clinical judgment based on severity is appropriate.
Tapering Guidelines
When Tapering is NOT Necessary
No taper is required for corticosteroid courses of less than 1 week 1, 2. For courses up to 10 days, tapering is probably unnecessary, especially if patients are concurrently taking inhaled corticosteroids 1, 2.
Supporting Evidence
- A pilot trial found no significant difference in relapse or rebound rates between tapering and non-tapering regimens in patients discharged from the emergency department 7
- The guideline explicitly states that for short courses (3-10 days), there is no evidence that tapering prevents relapse 5
When to Consider Tapering
- Long-term therapy (>10 days): If therapy extends beyond 10 days, gradual withdrawal is recommended rather than abrupt discontinuation 1, 2, 4
- Patients NOT on inhaled corticosteroids: Consider tapering if the patient is not concurrently using ICS 1, 2
Alternative Regimens
Dexamethasone Option
For adults, 16 mg/day of oral dexamethasone for 2 days is at least as effective as 5 days of prednisone 50 mg/day, with faster return to normal activities (90% vs 80% within 3 days) and similar relapse rates 8. In children, single-dose dexamethasone 0.3 mg/kg (maximum 12 mg) was as effective as 5 days of prednisolone 9.
Critical Prescribing Considerations
Concurrent Therapy
- Start inhaled corticosteroids immediately: ICS can be initiated at any point during treatment of an asthma exacerbation 1, 2
- Continue bronchodilators: Systemic corticosteroids are adjunctive to bronchodilator therapy 1
Common Pitfalls to Avoid
- Avoid SABA monotherapy: All patients with asthma should receive ICS-containing medication, not short-acting beta-agonists alone 10
- Don't delay oral steroids: Oral corticosteroids are as effective as IV when GI absorption is intact 1, 3
- Don't unnecessarily taper short courses: This adds complexity without proven benefit for courses ≤10 days 1, 7
- Monitor cumulative exposure: Even short courses carry risks (bone density loss, hypertension, GI bleeds); consider cumulative annual dose >1 g as a threshold for concern 11
Adverse Effects
Approximately 54% of patients report adverse effects attributable to prednisone during short courses 7. Lower doses (1 mg/kg vs 2 mg/kg in children) reduce vomiting frequency 6. Advise patients to take with food or milk to reduce gastric irritation 4.